Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The 2003 Australian Medicines Handbook was a clear, concise drug reference guide, updated with new topics and evidence, and considered essential for medical practice.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A gene called BMAL1 plays a role in controlling hair growth.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Balding hair follicles have reduced growth factors and increased inhibitory factors, suggesting new treatment paths for hair loss.

Encapsulated Garcinia mangostana extract in cream penetrates skin better than other forms.

MEF2C is crucial for normal hair cycle progression.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Mice with a Gsdma3 gene mutation have thicker skin and longer hair follicle openings due to increased β-catenin levels.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

cGEL hydrogel improves melanin production in skin cells, making it a promising option for skin treatments.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Skin cells and certain hair follicle areas produce hemoglobin, which may help protect against oxidative stress like UV damage.

AMH is a promising biomarker for diagnosing PCOS.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Somatic BHD mutations are rare in Japanese renal tumors.

MicroRNA-200 prevents sebaceous gland development by inhibiting SOX9 and cell cycle progression.

A specific gene mutation causes different hair defects in Indian monilethrix families.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Hsc70 protein may influence hair growth by responding to androgens.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.